Regentis Biomaterials Ltd. RGNT
1.20 USD +0.03 (+2.56%)
Nov 6, 2026, 1:11 PM EST
1.17 Day range 1.22
1.17 52-week range 15.50
- YTD
- -82.20%
- 1 year
- -84.00%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2001 Dec 31, 2001 | FY 2000 Dec 31, 2000 |
|---|---|---|---|---|---|
| -6.97M | 932.00K | -1.93M | -4.47M | -2.91M | |
| -13.65M | 4.80M | -4.13M | -1.33M | -6.47M | |
| -24.16 | 1.72 | -24.09 | -0.54 | -1.60 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2001 Dec 31, 2001 | FY 2000 Dec 31, 2000 |
|---|---|---|---|---|---|
| 7.38M | 229.00K | 345.00K | 5.02M | 6.25M | |
| 7.62M | 482.00K | 360.00K | 42.85M | 93.06M | |
| 2.87M | 6.49M | 11.17M | 57.76M | 104.16M | |
| 1.20M | 4.95M | 7.62M | 38.44M | 79.98M | |
| 4.74M | -41.10M | -45.91M | -14.98M | -12.53M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2001 Dec 31, 2001 | FY 2000 Dec 31, 2000 |
|---|---|---|---|---|---|
| -1.38M | -641.00K | -1.22M | -3.99M | -3.04M | |
| 8.52M | 525.00K | 325.00K | 4.41M | 44.72M | |
| 7.15M | -116.00K | -895.00K | 1.46M | -1.96M |